NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,127 filers reported holding NOVARTIS A G in Q1 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,276,227 | +1.1% | 81,251 | +0.2% | 1.76% | +8.2% |
Q2 2023 | $8,185,920 | +9.2% | 81,121 | -0.4% | 1.63% | +5.1% |
Q1 2023 | $7,496,712 | +9.5% | 81,486 | +8.0% | 1.55% | +9.5% |
Q4 2022 | $6,847,546 | +20.8% | 75,480 | +1.2% | 1.42% | +11.3% |
Q3 2022 | $5,669,000 | -9.0% | 74,579 | +1.2% | 1.27% | -3.0% |
Q2 2022 | $6,228,000 | -1.3% | 73,680 | +2.4% | 1.31% | +7.3% |
Q1 2022 | $6,313,000 | +4.1% | 71,946 | +3.7% | 1.22% | +7.7% |
Q4 2021 | $6,067,000 | +11.4% | 69,358 | +4.2% | 1.14% | +2.7% |
Q3 2021 | $5,444,000 | -2.9% | 66,566 | +8.4% | 1.10% | -10.7% |
Q2 2021 | $5,604,000 | +13.3% | 61,425 | +6.2% | 1.24% | +1.9% |
Q1 2021 | $4,946,000 | +0.1% | 57,861 | +10.5% | 1.21% | -12.4% |
Q4 2020 | $4,943,000 | +18.3% | 52,343 | +8.9% | 1.39% | -3.5% |
Q3 2020 | $4,180,000 | -0.9% | 48,069 | -0.5% | 1.44% | -6.1% |
Q2 2020 | $4,219,000 | +1672.7% | 48,302 | +1574.8% | 1.53% | +527.5% |
Q1 2020 | $238,000 | – | 2,884 | – | 0.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANAGED ASSET PORTFOLIOS, LLC | 335,936 | $29,213,000 | 5.81% |
Martin Investment Management, LLC | 170,759 | $14,849,000 | 5.36% |
Mawer Investment Management Ltd. | 8,515,391 | $740,498,000 | 4.84% |
SCHARF INVESTMENTS, LLC | 1,212,354 | $105,426,000 | 4.54% |
Hansberger Growth Investors, LP | 45,645 | $3,969,000 | 4.50% |
GARLAND CAPITAL MANAGEMENT INC | 50,905 | $4,427,000 | 3.95% |
First Fiduciary Investment Counsel, Inc. | 193,021 | $16,785,000 | 3.49% |
PROFESSIONAL ADVISORY SERVICES INC | 224,087 | $19,487,000 | 3.48% |
WOODLEY FARRA MANION PORTFOLIO MANAGEMENT INC | 362,047 | $31,484,000 | 3.29% |
WILKINS INVESTMENT COUNSEL INC | 126,470 | $10,998,000 | 3.28% |